[PSA] TB-500 is not what most of this community thinks it is
The one-line version is the title: TB-500 is not what most of this community thinks it is. The rest is why.
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
The three questions to ask before ordering anything from the long tail of a catalogue.
What exactly is it — catalogue number or sequence, not a common name, because several common names map to more than one molecule. How was identity established — mass against theoretical, ideally, rather than a bare purity figure. What are the storage conditions, stated specifically, with a state and a duration attached.
Then two commercial questions that save time: is this a stocked line or made to order, and what is the lead time in writing. All five are one email, and the shape of the reply tells you a great deal before any material moves.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.
best — the order this archive was captured in
Standing reminder: research-use-only material is not approved for human use, and no outcome claims without evidence.
Has anyone here tested that compound at all?
Correction: that name covers two different molecules and the thread has been discussing both as one.
Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
lead times on unusual lines are the thing to confirm up front
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
Right — ERP answered a handling question with actual storage conditions rather than a generic line, which is the standard.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
Disagree — that name refers to at least two different molecules depending on who is selling it. The thread needs to be specific.
a secretagogue and a fragment are not the same class of thing
This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.
That method was developed for a different compound class and would not resolve the impurities you are asking about.
the sequence is the product, everything else is packaging
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
Cosigning the lead-time point. Made-to-order and stocked are completely different propositions and both are legitimate.
- 1For any compound with a thin testing history, identity is the first…9 comments in this branch · started by u/naomi_antonsen